NPI: 1396932240 · WALLACE, NC 28466 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/25/2007
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/25/2007 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,151 | $32K |
| 2019 | 213 | $0.00 |
| 2020 | 6,348 | $50K |
| 2021 | 7,162 | $62K |
| 2022 | 7,227 | $114K |
| 2023 | 3,268 | $58K |
| 2024 | 1,168 | $49K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 14,607 | 1,045 | $324K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,912 | 608 | $30K |
| J1756 | Injection, iron sucrose, 1 mg | 1,418 | 385 | $6K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 124 | 64 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 890 | 75 | $651.92 |
| A4657 | Syringe, with or without needle, each | 477 | 409 | $0.00 |
| 83550 | 135 | 120 | $0.00 | |
| 82728 | 126 | 110 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 37 | 26 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $0.00 |
| 85048 | 256 | 219 | $0.00 | |
| 85041 | 244 | 207 | $0.00 | |
| 83540 | 135 | 120 | $0.00 | |
| 83970 | 163 | 149 | $0.00 |